Page last updated: 2024-10-17

2-aminoadipic acid and Benign Neoplasms, Brain

2-aminoadipic acid has been researched along with Benign Neoplasms, Brain in 2 studies

2-Aminoadipic Acid: A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; (NMDA).
2-aminoadipic acid : An alpha-amino acid that is adipic acid bearing a single amino substituent at position 2. An intermediate in the formation of lysine.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosi, A1
Ricci-Vitiani, L1
Biffoni, M1
Grande, S1
Luciani, AM1
Palma, A1
Runci, D1
Cappellari, M1
De Maria, R1
Guidoni, L1
Pallini, R1
Viti, V1
Campbell, GL1
Bartel, R1
Freidman, HS1
Bigner, DD1

Other Studies

2 other studies available for 2-aminoadipic acid and Benign Neoplasms, Brain

ArticleYear
(1) H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness.
    NMR in biomedicine, 2015, Volume: 28, Issue:3

    Topics: 2-Aminoadipic Acid; Adult; Aged; Biomarkers, Tumor; Brain Neoplasms; Cell Survival; Female; Glioblas

2015
Effect of glutamate analogues on brain tumor cell lines.
    Journal of neurochemistry, 1985, Volume: 45, Issue:4

    Topics: 2-Aminoadipic Acid; Aminobutyrates; Brain Neoplasms; Cell Division; Cell Line; Glioma; Glutamates; G

1985